Back to matchesWe found a matchYour institution may have rights to this item. Sign in to continue.TitleA double-blind, placebo-controlled phase II study of the efficacy and safety of 2,2-dimethylbutyrate (HQK-1001), an oral fetal globin inducer, in sickle cell disease.AuthorsReid, Marvin E.; Beshlawy, Amal; Inati, Adlette; Kutlar, Abdullah; Abboud, Miguel R.; Haynes, Johnson; Ward, Richard; Sharon, Bruce; Taher, Ali T.; Smith, Wally; Manwani, Deepa; Ghalie, Richard G.PublicationAmerican Journal of Hematology, 2014, Vol 89, Issue 7, p709ISSN0361-8609Publication typeArticleDOI10.1002/ajh.23725